Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Taysha Gene Therapies, Inc. (TSHA) had Return on Investments of -9.38% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$5.49M |
|
$-27.85M |
|
-- |
|
$5.49M |
|
$33.78M |
|
$-28.30M |
|
$0.45M |
|
$-27.85M |
|
$-27.85M |
|
$-27.85M |
|
$-27.85M |
|
$-27.85M |
|
$-27.85M |
|
$-28.30M |
|
$-28.00M |
|
319.71M |
|
319.71M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$324.65M |
|
$6.74M |
|
$18.67M |
|
$343.32M |
|
$26.55M |
|
$50.11M |
|
$69.83M |
|
$96.38M |
|
$246.94M |
|
$246.94M |
|
$246.94M |
|
285.05M |
|
| Cash Flow Statement Financials | |
$-93.09M |
|
$-0.60M |
|
$274.59M |
|
$141.64M |
|
$322.53M |
|
$180.90M |
|
$13.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.23 |
|
-- |
|
-- |
|
0.17 |
|
0.20 |
|
100.00% |
|
-515.95% |
|
-515.95% |
|
-- |
|
-507.77% |
|
-507.77% |
|
$-93.83M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-11.28% |
|
-11.28% |
|
-8.11% |
|
|
Return on Investments |
-9.38% |
$0.87 |
|
$-0.29 |
|
$-0.29 |
|